El regulador de la señalización de la proteína G RGS3 mejora la actividad de la GTPasa de KRAS
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Ver abstracta en PubMed
Resumen
Este resumen es generado por máquina.Los inhibidores de KRAS<sup>G12C</sup> se dirigen a la forma inactiva de la oncoproteína. Este estudio revela que RGS3 mejora la actividad de la KRAS GTPasa, lo que explica cómo funcionan estos inhibidores y cómo atacan el cáncer de pulmón de KRAS.
Área De La Ciencia
- En el campo de la oncología
- Biología molecular
- La bioquímica
Sus Antecedentes
- Los inhibidores de KRAS<sup>G12C</sup> se dirigen al estado ligado al difosfato de guanosina (GDP) inactivo.
- Las proteínas activadoras de la GTPasa (GAP) normalmente mejoran la hidrólisis de la GTP, pero las mutaciones KRAS impiden esto.
- El mecanismo que permite la inhibición de la hidrólisis de KRAS<sup>G12C</sup> GTP sigue sin estar claro.
Objetivo Del Estudio
- Investigar el mecanismo de la inactivación de KRAS.
- Para identificar los factores que mejoran la hidrólisis de GTP en el KRAS mutante.
- Para explicar la eficacia de los inhibidores de KRAS<sup>G12C</sup>.
Principales Métodos
- Se investigó la interacción entre las proteínas RGS3 y KRAS.
- Evaluó la actividad de la GTPasa del tipo salvaje y mutante KRAS en presencia de RGS3.
- Analizó el papel de RGS3 en la inactivación de KRAS.
Principales Resultados
- RGS3, un conocido regulador de los receptores acoplados a la proteína G, también mejora la actividad de la GTPasa de KRAS.
- RGS3 facilita la hidrólisis de GTP para las proteínas KRAS salvajes y mutantes.
- Este hallazgo proporciona un mecanismo para la inactivación de KRAS<sup>G12C</sup>.
Conclusiones
- RGS3 actúa inesperadamente como un GAP para KRAS, incluido el mutante G12C.
- Este mecanismo explica la susceptibilidad de KRAS<sup>G12C</sup> a las terapias emergentes.
- Identifica RGS3 como un actor clave en la regulación de KRAS y un objetivo terapéutico potencial.
Contact us Si estos videos no son relevantes.
Contact us Si estos videos no son relevantes.
Videos de Conceptos Relacionados
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Guanine nucleotide exchange factors or GEF,
GTPase-activating proteins or GAPs, and
Guanine nucleotide-dissociation inhibitors or GDIs.
The GEF activates the GTPase by exchanging the bound-GDP with GTP. The...
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...